Director at the Mayo Clinic and Mayo Clinic Laboratories In Rochester, Minnesota; Associate Professor of Medicine and Laboratory Medicine, Mayo Clinic College of Medicine and Science
BIOGRAPHY
JUN 07, 2022 10:00 AM PDT
New 2021 CDC HIV PrEP (Preexposure Prophylaxis) Guidelines: Implications for Clinicians and Laboratories
Speaker
Event Date & Time
Date: June 07, 2022
Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST)
Abstract
On December 8th, 2021 the CDC released new recommendations for preexposure prophylaxis (PrEP) for the prevention of HIV infection in the US. These new guidelines include important updates designed to help increase access to and awareness of PrEP as well as new recommendations for laboratory testing. This webinar will review these important changes and discuss how they will impact patients, clinicians, and the clinical laboratories providing results that play a critical role in this updated approach.
Learning Objectives
- Outline current HIV/PrEP landscape in the US
- Describe important changes in the new 2021 CDC PrEP Guidelines
- Review rationale of new recommendations for NAAT in PrEP monitoring and potential impact on clinical laboratories, clinicians, and patients
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 27, 2025 | 1:00 PM
C.E. CREDITS
Learn best practices for monitoring unfractionated heparin with aPTT, validating therapeutic ranges, and ensuring safe, effective anticoagulation....
OCT 28, 2025 | 7:00 AM
C.E. CREDITS
In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature...
OCT 28, 2025 | 9:00 AM
This webinar explains how CAR-T cells transfected using Solupore® technology from Avectas and sorted using the CGX10 Cell Isolation System from Sony Biotechnology outperform unsorted cel...
OCT 29, 2025 7:00 AM PT
This presentation explores the scientific rationale, preclinical validation, and early clinical translation of STAR-LLD—a novel, continuous low-dose percutaneous lenalidomide delivery...
OCT 29, 2025 | 8:00 AM
In today’s rapidly evolving landscape of next-generation sequencing (NGS), researchers face mounting pressure to deliver high-quality data from increasingly diverse and challenging sam...
OCT 29, 2025 | 9:00 AM
C.E. CREDITS
Congenital cytomegalovirus (cCMV) is the most common infectious cause of birth defects and non-genetic hearing loss in the United States, yet it remains underdiagnosed due to the absence of...
Loading Comments...